Last updated on February 2018

A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer


Brief description of study

The purpose of this study is to evaluate the serum testosterone levels in patients with Metastatic Castration-Resistant Prostate Cancer on SoluMatrix Abiraterone Acetate as Compared to Abiraterone Acetate

Detailed Study Description

This is 12-week, open-label study of abiraterone acetate in at least 50 patients with metastatic castration-resistant prostate cancer. The primary endpoint is total testosterone at pharmacokinetic steady-state. Additional secondary endpoints include safety assessments, PSA and pharmacokinetic measurements

Clinical Study Identifier: NCT02737332

Find a site near you

Start Over

Wichita Urology Group

Wichita, KS United States
  Connect »

Alliance Research

Laguna Hills, CA United States
  Connect »

Lincoln Urology, PC

Lincoln, NE United States
  Connect »

Tower Urology

Los Angeles, CA United States
  Connect »

San Bernardino Urological

San Bernardino, CA United States
  Connect »

Skyline Urology

Torrance, CA United States
  Connect »

Urology Associates, P.C.

Englewood, CO United States
  Connect »

Manatee Medical Research

Brandenton, FL United States
  Connect »

North Idaho Urology

Coeur D Alene, ID United States
  Connect »

The Iowa Clinic

West Des Moines, IA United States
  Connect »

Urology Cancer Center

Omaha, NE United States
  Connect »

Urology of Virginia

Virginia Beach, VA United States
  Connect »